Recent Updates
Recently added Catalysts
RDY

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: National Stock Exchange of India Ltd. (Scrip Code: BSE Limited (Scrip Code: 500124) Sub: Transcript of the Earnings call conducted on July 28, 2022 Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulatio

Full Press Release Details

National Stock Exchange of India Ltd. (Scrip Code:
BSE Limited (Scrip Code: 500124)
Sub: Transcript of the Earnings call conducted on July 28, 2022
Pursuant to Regulation 30 of Securities and Exchange
Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015, please
find enclosed the transcript of the Earnings call for the quarter ended June 30, 2022, conducted on July 28, 2022. Also please note that
this transcript of the call has been uploaded on our website.
The weblink to access it:
This is for your information.
For Dr. Reddy's Laboratories Limited
/s/ K Randhir Singh
K Randhir Singh
Company Secretary & Compliance Officer
CC:- New York Stock Exchange Inc.(Stock Code :RDY)
Last updated: Aug 3, 2022